Preterm Donor Human Milk Supplementation of Mother's Own Milk in VLBW Infants

Recruiting N/A Interventional Study
Prematurity
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 3 Weeks
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
200 (estimated)
Sponsor
National and Kapodistrian University of Athens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This prospective randomized controlled trial aims to investigate whether feeding very low birth weight (VLBW) infants with Mother's own milk (MOM) supplemented with either preterm (PDM) or term donor milk (TDM), when MOM is insufficient, has a positive impact on infants' protein intake, growth and morbidity.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: • VLBW infants with birth weight \<1500g born to mothers who agree to provide donor milk for the first three weeks of life (donor milk period) if their own milk quantity is insufficient Exclusion Criteria: * Congenital anomalies * Chromosomal disorders * Metabolic diseases * F…
Contacts

Tania Siahanidou, MD, PhD

+30 2132013517

siahan@med.uoa.gr

CONTACT

Giannoula Gialeli, MD

+30 2109758491

giannoula.g@gmail.com

CONTACT